NeurologyWire

AbbieVie Receives Approval for Carbidopa and Levodopa Pump

From NeurologyWire

FDA has approved Duopa (carbidopa and levodopa) enteral suspension for the treatment of motor fluctuations for people with advanced Parkinson's disease. Duopa is administered using a small, portable infusion pump that delivers carbidopa and levodopa directly into the small intestine for 16 continuous hours via a procedurally-placed tube.It was appr...

Login to read story

Wednesday, January 28, 2015

Show last days of articles

Why All Nighters Don't Work

From NeurologyWire

Want to ace that test tomorrow? Heres a tip: Put down the coffee and hit the sack.Scientists have long known that sleep, memory and learning are deepl...Full story

Tuesday, January 27, 2015

The Molecular Biology Behind ALS

From NeurologyWire

ALS is notoriously difficult to treat, and relatively little is known about exactly how and why it occurs. In a rare discovery, a clear molecular defe...Full story

Drug Candidates Can Block Cell-Death Pathway Associated with...

From NeurologyWire

In a pair of related studies, scientists have shown their drug candidates can target biological pathways involved in the destruction of brain cells in...Full story

Monday, January 26, 2015

Dysport Improves Muscle Tone in Hemiplegic and Diplegic Cere...

From NeurologyWire

Ipsen released topline results for two double-blind phase III studies of Dysport (abobotulinumtoxinA) in Pediatric Lower Limb (PLL) spasticity in chil...Full story

Flexible Work Schedules Improve Health, Sleep

From NeurologyWire

Giving employees more control over their work schedules may help curb sleep deficiency, according to health researchers."In the absence of sufficient ...Full story

Friday, January 23, 2015

DEA Removes Naloxegol from Schedule II Control

From NeurologyWire

The DEA has removed Naloxegol from the schedules of the Controlled Substance Act. FDA had approved naloxegol for marketing on September 16, 2014, unde...Full story

Study Examines Why Protein Mutations Lead to Familial Form o...

From NeurologyWire

Researchers say they have shown for the first time why protein mutations lead to the familial form of Parkinson's disease.The study, available online ...Full story

Potential Epilepsy Treatment Moves Forward to FDA, EU Review...

From NeurologyWire

UCB announced regulatory milestones in the US and the EU for its investigational antiepileptic drug brivaracetam. In the US, FDA has accepted for revi...Full story

Thursday, January 22, 2015

Global Consortium Attempts To Crack The Brains Genetic Code

From NeurologyWire

The identity of eight common gene mutations may one day reveal more about Alzheimers, autism and other neurological disorders.In the largest collabora...Full story

Stem Cell Transplantation Shows Potential for Reducing Disab...

From NeurologyWire

Results from a preliminary study indicate that among patients with relapsing-remitting multiple sclerosis (MS), treatment with nonmyeloablative hemato...Full story

Phase III MS Trial Underway

From NeurologyWire

Receptos has enrolled the first patient in the SUNBEAM Phase III trial of RPC1063 in patients with relapsing multiple sclerosis (RMS). The Company had...Full story

Wednesday, January 21, 2015

How The Brain Adapts After Blindness Surgeries

From NeurologyWire

Recent scientific advances have meant that eyesight can be partially restored to those who previously would have been blind for life. However, scienti...Full story

How Does The Brain Adapt After Blindness Surgeries?

From NeurologyWire

Recent scientific advances have meant that eyesight can be partially restored to those who previously would have been blind for life. However, scienti...Full story

In Review: A Look at Recent TBI Studies

From NeurologyWire

Exploring Similarities in Schizophrenia and TBIBoth schizophrenic and TBI patients were significantly poorer at recognizing facial emotions compared w...Full story

Portable Stimulator Being Tested on Parkinson's Patients

From NeurologyWire

The symptoms of Parkinson's are caused by a lack of the signal substance dopamine and is traditionally treated with medication. However, the balance p...Full story